GYNO-DAKTARIN® VC vaginal cream

Country: South Africa

Language: English

Source: South African Health Products Regulatory Authority (SAHPRA)

Available from:

Janssen

Patient Information leaflet

INDICATIONS [/za_1194.html#1]
  [/za_1194.html#1]     [/za_1194.html#1]
CONTRA-INDICATIONS [/za_1194.html#1]
      [/za_1194.html#1]
DOSAGE [/za_1194.html#1]
      [/za_1194.html#1]
SIDE-EFFECTS [/za_1194.html#1]
  [/za_1194.html#1]     [/za_1194.html#1]
PREGNANCY [/za_1194.html#1]
      [/za_1194.html#1]
OVERDOSE [/za_1194.html#1]

IDENTIFICATION [/za_1194.html#1]
  [/za_1194.html#1]    PATIENT INFORMATION
GYNO-DAKTARIN® VC VAGINAL CREAM
SCHEDULING STATUS
Schedule 2.
PROPRIETARY NAME
(and dosage form)
GYNO-DAKTARIN
®
 VC VAGINAL CREAM
COMPOSITION
Each 5 g contains 100 mg of the active substance, 
MICONAZOLE 
nitrate and 0,2% m/m of benzoic acid as preservative.
PHARMACOLOGICAL CLASSIFICATION
A.18.6 Medicines acting on the genito-urinary system. Vaginal preparations.
PHARMACOLOGICAL ACTION
PHARMACODYNAMICS
Miconazole combines a potent antifungal activity against common dermatophytes and yeasts with an antibacterial
activity against certain gram-positive bacilli and cocci.
Miconazole inhibits the biosynthesis of ergosterol in fungi and changes the composition of other lipid components in
the membrane, resulting in fungal cell necrosis.
PHARMACOKINETICS
Systemic absorption after intravaginal administration is limited. Unchanged miconazole could not be traced in blood
plasma or urine.
INDICATIONS
For the relief of vaginal itching, burning and discharge associated with recurrent vaginal yeast infections. (Vaginal
candidiasis).
CONTRA-INDICATIONS
GYNO-DAKTARIN* VC vaginal cream is contraindicated in individuals who have shown hypersensitivity to miconazole
nitrate or other ingredients of the cream.
WARNINGS
Use only if you have already had a vaginal yeast infection diagnosed by a medical practitioner and you have the same
symptoms now, otherwise consult your doctor. These symptoms include itching and burning of the